The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
Mirna-Based Therapies: Strategies and Delivery Platforms for Oligonucleotide and Non-Oligonucleotide Agents
Open accessAbstract
The discovery of miRNAs as important regulatory agents for gene expression has expanded the therapeutic opportunities for oligonucleotides. In contrast to siRNA, miRNA-targeted therapy is able to influence not only a single gene, but entire cellular pathways or processes. It is possible to supplement downregulated or non-functional miRNAs by synthetic oligonucleotides, as well as alleviating effects caused by overexpression of malignant miRNAs through artificial antagonists, either oligonucleotides or small molecules. Chemical oligonucleotide modifications together with an efficient delivery system seem to be mandatory for successful therapeutic application. While miRNA-based therapy benefits from the decades of research spent on other therapeutic oligonucleotides, there are some specific challenges associated with miRNA therapy, mainly caused by the short target sequence. The current status and recent progress of miRNA-targeted therapeutics is described and future challenges and potential applications in treatment of cancer and viral infections are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments
Bustin, S. A., Benes, V., Garson, J. A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M. W., Shipley, G. L., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.112797 · Cited by 16,303
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
Natural RNA circles function as efficient microRNA sponges
Hansen, T. B., Jensen, T. I., Clausen, B. H., Bramsen, J. B., Finsen, B., Damgaard, C. K., & Kjems, J. (2013) · Nature · doi:10.1038/nature11993 · Cited by 7,985
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
Real-time quantification of microRNAs by stem-loop RT-PCR
Chen, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni178 · Cited by 4,952
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930
Combinatorial microRNA target predictions
Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1536 · Cited by 4,603
Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., Guo, J., Zhang, Y., Chen, J., Guo, X., et al. (2008) · Cell Research · doi:10.1038/cr.2008.282 · Cited by 4,560
MicroRNA genes are transcribed by RNA polymerase II
Lee, Y., Kim, M., Han, J., Yeom, K., Lee, S., Baek, S. H., & Kim, V. N. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600385 · Cited by 4,373
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,095
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
RAS Is Regulated by the let-7 MicroRNA Family
Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,656
miR-15 and miR-16 induce apoptosis by targeting BCL2
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,517
An Abundant Class of Tiny RNAs with Probable Regulatory Roles in Caenorhabditis elegans
Lau, N. C., Lim, L. P., Weinstein, E. G., & Bartel, D. P. (2001) · Science · doi:10.1126/science.1065062 · Cited by 3,345
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115
Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs
Yi, R., Qin, Y., Macara, I. G., & Cullen, B. R. (2003) · Genes & Development · doi:10.1101/gad.1158803 · Cited by 3,010
Nuclear Export of MicroRNA Precursors
Lund, E., Güttinger, S., Calado, A., Dahlberg, J. E., & Kutay, U. (2004) · Science · doi:10.1126/science.1090599 · Cited by 2,714
The RIN: an RNA integrity number for assigning integrity values to RNA measurements
Schroeder, A., Mueller, O., Stocker, S., Salowsky, R., Leiber, M., Gassmann, M., Lightfoot, S., Menzel, W., Granzow, M., & Ragg, T. (2006) · BMC Molecular Biology · doi:10.1186/1471-2199-7-3 · Cited by 2,623
MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells
Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0137 · Cited by 2,557
MicroRNA maturation: stepwise processing and subcellular localization
Lee, Y. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf476 · Cited by 2,478
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
Poliseno, L., Salmena, L., Zhang, J., Carver, B., Haveman, W. J., & Pandolfi, P. P. (2010) · Nature · doi:10.1038/nature09144 · Cited by 2,323
Treatment of HCV Infection by Targeting MicroRNA
Janssen, H. L. A., Reesink, H. W., Lawitz, E. J., Zeuzem, S., Rodriguez-Torres, M., Patel, K., van der Meer, A. J., Patick, A. K., Chen, A., Zhou, Y., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209026 · Cited by 2,204
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,183
TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing
Chendrimada, T. P., Gregory, R. I., Kumaraswamy, E., Norman, J., Cooch, N., Nishikura, K., & Shiekhattar, R. (2005) · Nature · doi:10.1038/nature03868 · Cited by 2,100
Control of translation and mRNA degradation by miRNAs and siRNAs: Table 1.
Valencia-Sanchez, M. A., Liu, J., Hannon, G. J., & Parker, R. (2006) · Genes & Development · doi:10.1101/gad.1399806 · Cited by 2,060
Ketting, R. F., Fischer, S. E. J., Bernstein, E., Sijen, T., Hannon, G. J., & Plasterk, R. H. A. (2001) · Genes & Development · doi:10.1101/gad.927801 · Cited by 1,852
Rational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822 · cited 1×
“A plethora of literature reports of the development and preclinical evaluation of particulate systems has so far not been translated to clinical applications [8-10].”
BackgroundSystemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells
Ohno, S.-I., Takanashi, M., Sudo, K., Ueda, S., Ishikawa, A., Matsuyama, N., Fujita, K., Mizutani, T., Ohgi, T., Ochiya, T., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2012.180 · Cited by 1,666
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
Ng, E. W. M., Shima, D. T., Calias, P., Cunningham, E. T., Guyer, D. R., & Adamis, A. P. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1955 · Cited by 1,588
Molecular Basis for the Recognition of Primary microRNAs by the Drosha-DGCR8 Complex
Han, J., Lee, Y., Yeom, K.-H., Nam, J.-W., Heo, I., Rhee, J.-K., Sohn, S. Y., Cho, Y., Zhang, B.-T., & Kim, V. N. (2006) · Cell · doi:10.1016/j.cell.2006.03.043 · Cited by 1,551
MicroRNAs and other non-coding RNAs as targets for anticancer drug development
Ling, H., Fabbri, M., & Calin, G. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4140 · Cited by 1,465
Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
Kota, J., Chivukula, R. R., O'Donnell, K. A., Wentzel, E. A., Montgomery, C. L., Hwang, H.-W., Chang, T.-C., Vivekanandan, P., Torbenson, M., Clark, K. R., et al. (2009) · Cell · doi:10.1016/j.cell.2009.04.021 · Cited by 1,452
Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes.
Montecalvo, A., Larregina, A. T., Shufesky, W. J., Beer Stolz, D., Sullivan, M. L. G., Karlsson, J. M., Baty, C. J., Gibson, G. A., Erdos, G., Wang, Z., et al. (2012) · Blood · doi:10.1182/blood-2011-02-338004 · Cited by 1,429
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Liu, C., Kelnar, K., Liu, B., Chen, X., Calhoun-Davis, T., Li, H., Patrawala, L., Yan, H., Jeter, C., Honorio, S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2284 · Cited by 1,400
RNA polymerase III transcribes human microRNAs
Borchert, G. M., Lanier, W., & Davidson, B. L. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1167 · Cited by 1,393
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
Costello, J. F., Frühwald, M. C., Smiraglia, D. J., Rush, L. J., Robertson, G. P., Gao, X., Wright, F. A., Feramisco, J. D., Peltomäki, P., Lang, J. C., et al. (2000) · Nature Genetics · doi:10.1038/72785 · Cited by 1,357
Saito, Y., Liang, G., Egger, G., Friedman, J. M., Chuang, J. C., Coetzee, G. A., & Jones, P. A. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.020 · Cited by 1,335
Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms
Akinc, A., Querbes, W., De, S., Qin, J., Frank-Kamenetsky, M., Jayaprakash, K. N., Jayaraman, M., Rajeev, K. G., Cantley, W. L., Dorkin, J. R., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.85 · Cited by 1,261
Protocol: a highly sensitive RT-PCR method for detection and quantification of microRNAs
Varkonyi-Gasic, E., Wu, R., Wood, M., Walton, E. F., & Hellens, R. P. (2007) · Plant Methods · doi:10.1186/1746-4811-3-12 · Cited by 1,186
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
Akinc, A., Zumbuehl, A., Goldberg, M., Leshchiner, E. S., Busini, V., Hossain, N., Bacallado, S. A., Nguyen, D. N., Fuller, J., Alvarez, R., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1402 · Cited by 1,150
Jansson, M. D., & Lund, A. H. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.09.006 · Cited by 1,099
Jackson, A. L., & Linsley, P. S. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3010 · Cited by 1,083
Clinical relevance of circulating cell-free microRNAs in cancer
Schwarzenbach, H., Nishida, N., Calin, G. A., & Pantel, K. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.5 · Cited by 969
Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer
Huang, Z., Huang, D., Ni, S., Peng, Z., Sheng, W., & Du, X. (2010) · International Journal of Cancer · doi:10.1002/ijc.25007 · Cited by 964
MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy
Kasinski, A. L., & Slack, F. J. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3166 · Cited by 936
Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies
Pritchard, C. C., Kroh, E., Wood, B., Arroyo, J. D., Dougherty, K. J., Miyaji, M. M., Tait, J. F., & Tewari, M. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0370 · Cited by 879
Zeng, Y., Wagner, E. J., & Cullen, B. R. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00541-5 · Cited by 831
Peltier, H. J., & Latham, G. J. (2008) · RNA · doi:10.1261/rna.939908 · Cited by 820
MicroRNA sponges: Progress and possibilities
Ebert, M. S., & Sharp, P. A. (2010) · RNA · doi:10.1261/rna.2414110 · Cited by 762
Short RNAs Repress Translation after Initiation in Mammalian Cells
Petersen, C. P., Bordeleau, M.-E., Pelletier, J., & Sharp, P. A. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.031 · Cited by 761
miR-34 – a microRNA replacement therapy is headed to the clinic
Bader, A. G. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00120 · Cited by 728
Rayner, K. J., Sheedy, F. J., Esau, C. C., Hussain, F. N., Temel, R. E., Parathath, S., van Gils, J. M., Rayner, A. J., Chang, A. N., Suarez, Y., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57275 · Cited by 690
Trang, P., Wiggins, J. F., Daige, C. L., Cho, C., Omotola, M., Brown, D., Weidhaas, J. B., Bader, A. G., & Slack, F. J. (2011) · Molecular Therapy · doi:10.1038/mt.2011.48 · Cited by 667
Extracellular microRNA: A new source of biomarkers
Etheridge, A., Lee, I., Hood, L., Galas, D., & Wang, K. (2011) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.03.004 · Cited by 659
MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis
Kurowska-Stolarska, M., Alivernini, S., Ballantine, L. E., Asquith, D. L., Millar, N. L., Gilchrist, D. S., Reilly, J., Ierna, M., Fraser, A. R., Stolarski, B., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019536108 · Cited by 641
Human Dicer preferentially cleaves dsRNAs at their termini without a requirement for ATP
Zhang, H. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf582 · Cited by 631
Silencing of microRNA families by seed-targeting tiny LNAs
Obad, S., dos Santos, C. O., Petri, A., Heidenblad, M., Broom, O., Ruse, C., Fu, C., Lindow, M., Stenvang, J., Straarup, E. M., et al. (2011) · Nature Genetics · doi:10.1038/ng.786 · Cited by 627
MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles
van Rooij, E., & Olson, E. N. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3864 · Cited by 624
Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA
Braasch, D. A., & Corey, D. R. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00058-2 · Cited by 605
Negative Feedback Regulation of Dicer-Like1 in Arabidopsis by microRNA-Guided mRNA Degradation
Xie, Z., Kasschau, K. D., & Carrington, J. C. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00281-1 · Cited by 583
Zhang, Y., Wang, Z., & Gemeinhart, R. A. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.015 · Cited by 535
van Rooij, E. (2011) · Circulation Research · doi:10.1161/circresaha.110.227496 · Cited by 534
Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy
Chen, Y., Zhu, X., Zhang, X., Liu, B., & Huang, L. (2010) · Molecular Therapy · doi:10.1038/mt.2010.136 · Cited by 515
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer
Zhang, L., Volinia, S., Bonome, T., Calin, G. A., Greshock, J., Yang, N., Liu, C.-G., Giannakakis, A., Alexiou, P., Hasegawa, K., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801615105 · Cited by 511
Comparative analysis of RNA sequencing methods for degraded or low-input samples
Adiconis, X., Borges-Rivera, D., Satija, R., DeLuca, D. S., Busby, M. A., Berlin, A. M., Sivachenko, A., Thompson, D. A., Wysoker, A., Fennell, T., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2483 · Cited by 503
A blood based 12-miRNA signature of Alzheimer disease patients
Leidinger, P., Backes, C., Deutscher, S., Schmitt, K., Mueller, S. C., Frese, K., Haas, J., Ruprecht, K., Paul, F., Stähler, C., et al. (2013) · Genome Biology · doi:10.1186/gb-2013-14-7-r78 · Cited by 502
Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma
Babar, I. A., Cheng, C. J., Booth, C. J., Liang, X., Weidhaas, J. B., Saltzman, W. M., & Slack, F. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201516109 · Cited by 497
Rapid Alteration of MicroRNA Levels by Histone Deacetylase Inhibition
Scott, G. K., Mattie, M. D., Berger, C. E., Benz, S. C., & Benz, C. C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3632 · Cited by 492
Diagnostic and Prognostic MicroRNAs in Stage II Colon Cancer
Schepeler, T., Reinert, J. T., Ostenfeld, M. S., Christensen, L. L., Silahtaroglu, A. N., Dyrskjøt, L., Wiuf, C., Sørensen, F. J., Kruhøffer, M., Laurberg, S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6110 · Cited by 492
Evidence for an instructive mechanism of de novo methylation in cancer cells
Keshet, I., Schlesinger, Y., Farkash, S., Rand, E., Hecht, M., Segal, E., Pikarski, E., Young, R. A., Niveleau, A., Cedar, H., et al. (2006) · Nature Genetics · doi:10.1038/ng1719 · Cited by 478
MicroRNA history: Discovery, recent applications, and next frontiers
Almeida, M. I., Reis, R. M., & Calin, G. A. (2011) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.03.009 · Cited by 466
Lipid-based systemic delivery of siRNA
Tseng, Y.-C., Mozumdar, S., & Huang, L. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.003 · Cited by 463
McManus, M. T. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(03)00038-5 · Cited by 439
Small RNAs with Imperfect Match to Endogenous mRNA Repress Translation
Saxena, S., Jónsson, Z. O., & Dutta, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307089200 · Cited by 436
Chemical modification and design of anti-miRNA oligonucleotides
Lennox, K. A., & Behlke, M. A. (2011) · Gene Therapy · doi:10.1038/gt.2011.100 · Cited by 433
MicroRNA gene expression profile of hepatitis C virus–associated hepatocellular carcinoma†‡
Varnholt, H., Drebber, U., Schulze, F., Wedemeyer, I., Schirmacher, P., Dienes, H., & Odenthal, M. (2008) · Hepatology · doi:10.1002/hep.22158 · Cited by 431
Small‐Molecule Inhibitors of MicroRNA miR‐21 Function
Gumireddy, K., Young, D. D., Xiong, X., Hogenesch, J. B., Huang, Q., & Deiters, A. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200801555 · Cited by 427
Phosphorothioate Oligodeoxynucleotides: What Is Their Origin and What Is Unique About Them?
ECKSTEIN, F. (2000) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.2000.10.117 · Cited by 382
Bramsen, J. B., Laursen, M. B., Nielsen, A. F., Hansen, T. B., Bus, C., Langkjær, N., Babu, B. R., Højland, T., Abramov, M., Van Aerschot, A., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp106 · Cited by 369
Miravirsen (SPC3649) can inhibit the biogenesis of miR-122
Gebert, L. F. R., Rebhan, M. A. E., Crivelli, S. E. M., Denzler, R., Stoffel, M., & Hall, J. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt852 · Cited by 364
Di Leva, G., & Croce, C. M. (2013) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.01.004 · Cited by 356
EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2
Shen, J., Xia, W., Khotskaya, Y. B., Huo, L., Nakanishi, K., Lim, S.-O., Du, Y., Wang, Y., Chang, W.-C., Chen, C.-H., et al. (2013) · Nature · doi:10.1038/nature12080 · Cited by 356
Ruvkun, G. (2001) · Science · doi:10.1126/science.1066315 · Cited by 355
Sequence-based design of bioactive small molecules that target precursor microRNAs
Velagapudi, S. P., Gallo, S. M., & Disney, M. D. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1452 · Cited by 327
Rand, T. A., Ginalski, K., Grishin, N. V., & Wang, X. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405913101 · Cited by 324
MicroRNA-21: A novel therapeutic target in human cancer
Pan, X., Wang, Z.-X., & Wang, R. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.12.14252 · Cited by 322
Diabetes Complications: The MicroRNA Perspective
Kantharidis, P., Wang, B., Carew, R. M., & Lan, H. Y. (2011) · Diabetes · doi:10.2337/db11-0082 · Cited by 289
Gee, H. E., Buffa, F. M., Camps, C., Ramachandran, A., Leek, R., Taylor, M., Patil, M., Sheldon, H., Betts, G., Homer, J., et al. (2011) · British Journal of Cancer · doi:10.1038/sj.bjc.6606076 · Cited by 283
Alajez, N. M., Lenarduzzi, M., Ito, E., Hui, A. B. Y., Shi, W., Bruce, J., Yue, S., Huang, S. H., Xu, W., Waldron, J., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2754 · Cited by 283
MicroRNA-7a regulates pancreatic β cell function
Latreille, M., Hausser, J., Stützer, I., Zhang, Q., Hastoy, B., Gargani, S., Kerr-Conte, J., Pattou, F., Zavolan, M., Esguerra, J. L. S., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73066 · Cited by 281
Overexpression of Exportin 5 enhances RNA interference mediated by short hairpin RNAs and microRNAs
YI, R., DOEHLE, B. P., QIN, Y., MACARA, I. G., & CULLEN, B. R. (2005) · RNA · doi:10.1261/rna.7233305 · Cited by 278
Methylation of Human MicroRNA Genes in Normal and Neoplastic Cells
Weber, B., Stresemann, C., Brueckner, B., & Lyko, F. (2007) · Cell Cycle · doi:10.4161/cc.6.9.4209 · Cited by 275
Wang, H., Bian, S., & Yang, C. S. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr218 · Cited by 261
Young, D. D., Connelly, C. M., Grohmann, C., & Deiters, A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja910275u · Cited by 260
Circulating MicroRNAs as biomarkers for disease staging in multiple sclerosis
Gandhi, R., Healy, B., Gholipour, T., Egorova, S., Musallam, A., Hussain, M. S., Nejad, P., Patel, B., Hei, H., Khoury, S., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23880 · Cited by 258
Lipid-Based Nanoparticles for siRNA Delivery in Cancer Therapy: Paradigms and Challenges
Gomes-da-Silva, L. C., Fonseca, N. A., Moura, V., Pedroso de Lima, M. C., Simões, S., & Moreira, J. N. (2012) · Accounts of Chemical Research · doi:10.1021/ar300048p · Cited by 254
Melo, S., Villanueva, A., Moutinho, C., Davalos, V., Spizzo, R., Ivan, C., Rossi, S., Setien, F., Casanovas, O., Simo-Riudalbas, L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014720108 · Cited by 253
Fabani, M. M., & Gait, M. J. (2008) · RNA · doi:10.1261/rna.844108 · Cited by 252
Yang, Y.-P., Chien, Y., Chiou, G.-Y., Cherng, J.-Y., Wang, M.-L., Lo, W.-L., Chang, Y.-L., Huang, P.-I., Chen, Y.-W., Shih, Y.-H., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.071 · Cited by 240
Sticky overhangs enhance siRNA-mediated gene silencing
Bolcato-Bellemin, A.-L., Bonnet, M.-E., Creusat, G., Erbacher, P., & Behr, J.-P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707831104 · Cited by 236
Hwang, D. W., Son, S., Jang, J., Youn, H., Lee, S., Lee, D., Lee, Y.-S., Jeong, J. M., Kim, W. J., & Lee, D. S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.047 · Cited by 234
Tivnan, A., Orr, W. S., Gubala, V., Nooney, R., Williams, D. E., McDonagh, C., Prenter, S., Harvey, H., Domingo-Fernández, R., Bray, I. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038129 · Cited by 233
Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung Cancer
Wu, Y., Crawford, M., Mao, Y., Lee, R. J., Davis, I. C., Elton, T. S., Lee, L. J., & Nana-Sinkam, S. P. (2013) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2013.14 · Cited by 223
An antagomir to microRNA Let7f promotes neuroprotection in an ischemic stroke model
Selvamani, A., Sathyan, P., Miranda, R. C., & Sohrabji, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032662 · Cited by 217
Selective Depletion of rRNA Enables Whole Transcriptome Profiling of Archival Fixed Tissue
Morlan, J. D., Qu, K., & Sinicropi, D. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042882 · Cited by 216
Epigenetic regulation of microRNAs in cancer: An integrated review of literature
Kunej, T., Godnic, I., Ferdin, J., Horvat, S., Dovc, P., & Calin, G. A. (2011) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.03.008 · Cited by 205
MicroRNA dysregulation in schizophrenia
Beveridge, N. J., & Cairns, M. J. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.029 · Cited by 205
CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia
Chen, Y., Jacamo, R., Konopleva, M., Garzon, R., Croce, C., & Andreeff, M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66553 · Cited by 202
Johnson, S. M., Lin, S.-Y., & Slack, F. J. (2003) · Developmental Biology · doi:10.1016/s0012-1606(03)00202-1 · Cited by 187
Small RNA asymmetry in RNAi: Function in RISC assembly and gene regulation
Hutvagner, G. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.08.071 · Cited by 186
MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma
Jin, L., Hu, W. L., Jiang, C. C., Wang, J. X., Han, C. C., Chu, P., Zhang, L. J., Thorne, R. F., Wilmott, J., Scolyer, R. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019312108 · Cited by 176
Silencing of microRNA‐21 in vivo ameliorates autoimmune splenomegaly in lupus mice
Garchow, B. G., Bartulos Encinas, O., Leung, Y. T., Tsao, P. Y., Eisenberg, R. A., Caricchio, R., Obad, S., Petri, A., Kauppinen, S., & Kiriakidou, M. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100171 · Cited by 174
Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor
Hsu, S.-H., Yu, B., Wang, X., Lu, Y., Schmidt, C. R., Lee, R. J., Lee, L. J., Jacob, S. T., & Ghoshal, K. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2013.05.007 · Cited by 173
Regulation of microRNAs in cancer metastasis
Bouyssou, J. M. C., Manier, S., Huynh, D., Issa, S., Roccaro, A. M., & Ghobrial, I. M. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.02.002 · Cited by 173
MicroRNA Delivery by Cationic Lipoplexes for Lung Cancer Therapy
Wu, Y., Crawford, M., Yu, B., Mao, Y., Nana-Sinkam, S. P., & Lee, L. J. (2011) · Molecular Pharmaceutics · doi:10.1021/mp2002076 · Cited by 172
MicroRNAs as therapeutic targets in cancer
Nana-Sinkam, S. P., & Croce, C. M. (2011) · Translational Research · doi:10.1016/j.trsl.2011.01.013 · Cited by 168
miR‐137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6
Zhu, X., Li, Y., Shen, H., Li, H., Long, L., Hui, L., & Xu, W. (2013) · FEBS Letters · doi:10.1016/j.febslet.2012.11.004 · Cited by 162
miRNAs and cancer: An epigenetics view
Malumbres, M. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.06.005 · Cited by 155
Oligonucleotide Conjugates for Therapeutic Applications
Winkler, J. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.47 · Cited by 154
Self-citationWang, L., Guo, Z., Zhang, R., Xin, B., Chen, R., Zhao, J., Wang, T., Wen, W., Jia, L., Yao, L.-B., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt139 · Cited by 148
Piao, L., Zhang, M., Datta, J., Xie, X., Su, T., Li, H., Teknos, T. N., & Pan, Q. (2012) · Molecular Therapy · doi:10.1038/mt.2012.67 · Cited by 146
Chiou, G., Cherng, J., Hsu, H., Wang, M., Tsai, C., Lu, K., Chien, Y., Hung, S., Chen, Y., Wong, C.-I., et al. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.014 · Cited by 146
Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease.
Gaughwin, P. M., Ciesla, M., Lahiri, N., Tabrizi, S. J., Brundin, P., & Björkqvist, M. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr111 · Cited by 145
microRNA Replacement Therapy for Cancer
Henry, J. C., Azevedo‐Pouly, A. C. P., & Schmittgen, T. D. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0548-9 · Cited by 144
Solanas, M., Moral, R., & Escrich, E. (2001) · Analytical Biochemistry · doi:10.1006/abio.2000.4889 · Cited by 141
Redshaw, N. M., Wilkes, T. M., Whale, A. S., Cowen, S., Huggett, J. F., & Foy, C. A. (2013) · BioTechniques · doi:10.2144/000114002 · Cited by 132
Development of a microRNA delivery system based on bacteriophage MS2 virus‐like particles
Pan, Y., Zhang, Y., Jia, T., Zhang, K., Li, J., & Wang, L. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08512.x · Cited by 129
Zamaratski, E., Pradeepkumar, P. I., & CHATTOPADHYAYA, J. B. (2001) · Journal of Biochemical and Biophysical Methods · doi:10.1016/s0165-022x(01)00149-x · Cited by 126
Dirin, M., & Winkler, J. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.774366 · Cited by 120
Self-citationThe role of microRNAs in the regulation of cancer stem cells
Takahashi, R.-U., Miyazaki, H., & Ochiya, T. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2013.00295 · Cited by 118
Wang, Y., Zheng, X., Zhang, Z., Zhou, J., Zhao, G., Yang, J., Xia, L., Wang, R., Cai, X., Hu, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041693 · Cited by 116
Kang, K., Zhang, X., Liu, H., Wang, Z., Zhong, J., Huang, Z., Peng, X., Zeng, Y., Wang, Y., Yang, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048536 · Cited by 112
Liu, X., Liu, C., Laurini, E., Posocco, P., Pricl, S., Qu, F., Rocchi, P., & Peng, L. (2011) · Molecular Pharmaceutics · doi:10.1021/mp2006104 · Cited by 110
Small Molecule Modifiers of the microRNA and RNA Interference Pathway
Deiters, A. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9159-3 · Cited by 104
Systemic Delivery of microRNA‐34a for Cancer Stem Cell Therapy
Shi, S., Han, L., Gong, T., Zhang, Z., & Sun, X. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201208077 · Cited by 100
Fattal, E., & BARRATT, G. M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00148.x · Cited by 99
Polymer nanoparticle-mediated delivery of microRNA inhibition and alternative splicing
Cheng, C. J., & Saltzman, W. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300081s · Cited by 92
MicroRNA-145 suppresses hepatocellular carcinoma by targeting IRS1 and its downstream Akt signaling
Wang, Y., Chen, H., Cheng, J., Chen, B., Ke, Q., Lv, Z., Wu, J., & Zhou, Y. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.03.107 · Cited by 89
Chen, Y., Ke, G., Han, D., Liang, S., Yang, G. S., & Wu, X. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.10.014 · Cited by 87
Law, P. T. Y., Ching, A. K.-K., Chan, A. W. H., Wong, Q. W.-L., Wong, C.-K., To, K., & Wong, N. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs130 · Cited by 87
Zheng, L., Pu, J., Qi, T., Meng, Q., Li, D., Xiang, X., Huang, K., & Tong, Q. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0534 · Cited by 86
MicroRNA-338 Inhibits Growth, Invasion and Metastasis of Gastric Cancer by Targeting NRP1 Expression
Yang, P., Liu, Y., LI, L.-C., Wang, L., & Wu, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094422 · Cited by 85
Xia, H., & Hui, K. M. (2012) · Cancer Gene Therapy · doi:10.1038/cgt.2012.58 · Cited by 81
Yang, F., Nam, S., Brown, C. E., Zhao, R., Starr, R., Horne, D. A., Malkas, L. H., Jove, R., & Hickey, R. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094443 · Cited by 74
Molecular Pathways: MicroRNAs as Cancer Therapeutics
Melo, S. A., & Kalluri, R. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2010 · Cited by 73
Zhou, P., Huang, G., Zhao, Y., Zhong, D., Xu, Z., Zeng, Y., Zhang, Y., Li, S., & He, F. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.02.020 · Cited by 70
Grillone, L. R., & Lanz, R. (2001) · Drugs of today · doi:10.1358/dot.2001.37.4.620590 · Cited by 69
microRNAs, an active and versatile group in cancers
Liu, J., Zheng, M. H., Tang, Y., Liang, X., & Yang, Q. (2011) · International Journal of Oral Science · doi:10.4248/ijos11063 · Cited by 67
MetastamiRs: Non-Coding MicroRNAs Driving Cancer Invasion and Metastasis
López‐Camarillo, C., Marchat, L. A., Aréchaga-Ocampo, E., Pérez‐Plasencia, C., Moral-Hernández, Ó. D., Castaneda-Ortiz, E. J., & Rodriguez-Cuevas, S. A. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13021347 · Cited by 67
miR-137 suppresses cell growth in ovarian cancer by targeting AEG-1
Guo, J., Xia, B., Meng, F., & Lou, G. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.10.052 · Cited by 60
Shielding the messenger (RNA): microRNA-based anticancer therapies
Sotillo, E., & Thomas‐Tikhonenko, A. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.04.006 · Cited by 60
Two-dimensional combinatorial screening enables the bottom-up design of a microRNA-10b inhibitor
Velagapudi, S. P., & Disney, M. D. (2014) · Chemical Communications · doi:10.1039/c3cc00173c · Cited by 57
Yao, Y., Xue, Y., Ma, J., Shang, C., Wang, P., Liu, L., Liu, W., Li, Z., Qu, S., Li, Z., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095060 · Cited by 55
Ye, X., Liu, Z., Hemida, M. G., & Yang, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021215 · Cited by 55
Identification and analysis of the proximal promoters of microRNA genes in Arabidopsis
Zhao, X., Zhang, H., & Li, L. (2013) · Genomics · doi:10.1016/j.ygeno.2012.12.004 · Cited by 53
Enhancement of RNAi by a small molecule antibiotic enoxacin
Zhang, Q., Zhang, C., & Xi, Z. (2008) · Cell Research · doi:10.1038/cr.2008.287 · Cited by 52
Hagiwara, K., Ochiya, T., & Kosaka, N. (2013) · Drug Delivery and Translational Research · doi:10.1007/s13346-013-0180-9 · Cited by 44
Enoxacin Elevates MicroRNA Levels in Rat Frontal Cortex and Prevents Learned Helplessness
Smalheiser, N. R., Zhang, H., & Dwivedi, Y. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00006 · Cited by 43
Parhofer, K. G. (2012) · Core evidence · doi:10.2147/ce.s25239 · Cited by 43
MicroRNA-targeting therapeutics for hepatitis C
Baek, J., Kang, S., & Min, H. (2014) · Archives of pharmacal research · doi:10.1007/s12272-013-0318-9 · Cited by 35
MicroRNAs and Cancer Therapeutics
Yeung, M. L., & Jeang, K. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0526-2 · Cited by 32
Antagomirs and micro RNA in status epilepticus
Henshall, D. C. (2013) · Epilepsia · doi:10.1111/epi.12267 · Cited by 28
Nanomedicines Based on Recombinant Fusion Proteins for Targeting Therapeutic siRNA Oligonucleotides
Winkler, J. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.56 · Cited by 28
Self-citationReview of Phase II and Phase III clinical trials for Duchenne muscular dystrophy
Scully, M. A., Pandya, S., & Moxley, R. T. (2012) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2013.746939 · Cited by 21
Meyer, F. R. L., Grausgruber, H., Binter, C., Mair, G. E., Guelly, C., Vogl, C., & Steinborn, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063125 · Cited by 13
Arresting the Culprit: Targeted Antagomir Delivery to Sequester Oncogenic miR-221 in HCC
Kasinski, A. L., & Slack, F. J. (2012) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2012.2 · Cited by 12
Cited by
Noncoding RNA therapeutics—Challenges and potential solutions
Winkle, M., El-Daly, S. M., Fabbri, M., & Calin, G. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00219-z · Cited by 1,551
Regulation of microRNA biogenesis and its crosstalk with other cellular pathways
Treiber, T., Treiber, N., & Meister, G. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0059-1 · Cited by 1,252
The delivery of therapeutic oligonucleotides
Juliano, R. L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw236 · Cited by 854
RNAi-based therapeutics and tumor targeted delivery in cancer
Kara, G., Calin, G. A., & Ozpolat, B. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114113 · Cited by 411
Liang, Y., Xu, X., Li, X., Xiong, J., Li, B., Duan, L., Wang, D., & Xia, J. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c10458 · Cited by 391
Metadata
- Authors
- Baumann, V., & Winkler, J.
- Venue
- Future Medicinal Chemistry
- Publisher
- Informa UK Limited
- Published
- 2014-11
- Volume
- 6
- Issue
- 17
- Pages
- 1967-1984
- ISSN
- 1756-8919 (ISSN-L)
- 1756-8927
- OpenAlex
- W2059310361
- Cited by
- 297
- References
- 171
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.